Advertisement

Complicated eclampsia

Fifteen years’ experience in a referral medical center
  • M. Mario López-Llera
    Correspondence
    Nicolás San Juan 1031, Colania del Valle, 03100 Mexico, D.F
    Affiliations
    From the Hospital de Gineco-Obstetricia No. 2 del Centro Médico Nacional del Instituto Mexicano del Seguro Social, and the Department of Obstetrics and Gynecology, National University of México School of Medicine, Mexico Cily, Mexico
    Search for articles by this author
      This paper is only available as a PDF. To read, Please Download here.
      The statistical study of a large number of eclamptic patients (n=704), divided into five successive 3-year periods, was undertaken at the Hospital de Gineco-Obstetricia No. 2 del Centro Médico Nacional in Mexico City in order to detect significant changes in the therapeutic results and/or in the basic character of the disease, as it occurs in a large referral medical complex. The following variables were studied: maternal and perinatal deaths, obstetric profile, main clinical data of the eclamptic episode, frequency of cesarean operation, timing of delivery after admission, main therapeutic changes, frequency of complications in survivors of ante- and intrapartum eclampsia, and cause of death with associated complications. The study showed (1) a continuous increment in the number of cases from the first to the last period, (2) averages for maternal age (24.9±0.45 years) and for previous parity (1.7±0.19) unlike those commonly accepted, (3) a significant progression in the severity of the disease in recent years, (4) a frequency of 22.9% of important complications in survivors of ante- and intrapartum eclampsia, (5) a very limited overall influence of some therapeutic changes on the final outcome of complicated eclampsia, and (6) the impossibility of improving morbidity figures significantly during the 15 years of the study. It was concluded that prevention, early diagnosis, and timely simple medical care offer the only perspective for true medical progress in this particular problem.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to American Journal of Obstetrics & Gynecology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      REFERENCES

        • López-Llera M.
        Eclampsia 1963-1966. Evaluation of the treatment of 107 cases.
        J. Obstet. Gynaecol. Br. Commonw. 1967; 74: 379
        • López-Llera M.
        • Rubio Linares G.
        Some aspects of the toxemic syndrome in a sector of the Mexican population.
        J. Reprod. Med. 1970; 4: 114
        • López-Llera M.
        • Rubio Linares G.
        • Hernández Horta J.L.
        Maternal mortality rates in eclampsia.
        Am. J. Obstet. Gynecol. 1976; 124: 149
        • Pritchard J.A.
        Standardized treatment of 154 consecutive cases of eclampsia.
        Am. J. Obstet. Gynecol. 1975; 123: 543
        • Thomson A.M.
        • Billewicz W.Z.
        • Hytten F.
        The assessment of fetal growth.
        J. Obstet. Gynaecol. Br. Commonw. 1968; 75: 903